WHAT IS THE PROGNOSTIC VALUE OF OSTEOMEDULLARY UPTAKE ON METAIODOBENZYLGUANIDINE SCAN IN NEUROBLASTOMA PATIENTS UNDER ONE-YEAR OF AGE

被引:17
作者
DECERVENS, CL
HARTMANN, O
BONNIN, F
COUANET, D
VALTEAUCOUANET, D
LUMBROSO, J
BEHAR, C
MARTELLI, H
LEMERLE, J
机构
[1] INST GUSTAVE ROUSSY,DEPT PEDIAT,39 RUE CAMILLE DESMOULINS,F-94805 VILLEJUIF,FRANCE
[2] INST GUSTAVE ROUSSY,DEPT NUCL MED,F-94805 VILLEJUIF,FRANCE
[3] INST GUSTAVE ROUSSY,DEPT RADIOL,F-94805 VILLEJUIF,FRANCE
[4] MEM HOSP,DEPT PEDIAT,REIMS,FRANCE
[5] HOP NECKER ENFANTS MALAD,DEPT SURG,F-75730 PARIS 15,FRANCE
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 1994年 / 22卷 / 02期
关键词
NEUROBLASTOMA; METASTASES; INFANTS; METAIODOBENZYLGUANIDINE;
D O I
10.1002/mpo.2950220209
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Twenty-seven infants under one year of age with metastatic neuroblastoma were studied for osteomedullary metastases. They were evaluated by at least two imaging procedures: X-ray films and MIBG scan. Taking into account the results of these investigations, 3 groups were defined: osteomedullary metastases were detected in 8 infants by both X-ray and MIBG scan, no osteomedulary sites were detected by either technique in 13 patients, and 6 had osteomedullary foci with positive MIBG uptake but no radiological abnormality. These three groups were apparently different in terms of median age, response to chemotherapy, and long-term survival. The third group, which has not been previously described, appears to have a better prognosis than patients with radiologically detectable bone lesions. Nevertheless it was necessary to use intensive chemotherapy to obtain remission in these particular patients. it should be mandatory to specify the investigatory technique used to describe osteomedullary metastases in infants and treatment should be adapted according to this grouping system. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 22 条
[1]  
BONNIN F, 1992, 1ST EUR S PED NUCL M
[2]  
DANGIO GJ, 1971, LANCET, V1, P1046
[3]  
DECERVENS CL, 1990, ARCH FR PEDIATR, V47, P91
[4]   DO INFANTS WITH STAGE IV-S NEURO-BLASTOMA NEED TREATMENT [J].
EVANS, AE ;
BAUM, E ;
CHARD, R .
ARCHIVES OF DISEASE IN CHILDHOOD, 1981, 56 (04) :271-274
[5]  
EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO
[6]  
2-G
[7]   NEURO-BLASTOMA - IMAGING EVALUATION BY SEQUENTIAL TC-99M MDP, I-131 MIBG, AND GA-67-CITRATE STUDIES [J].
GARTY, I ;
FRIEDMAN, A ;
SANDLER, MP ;
KEDAR, A .
CLINICAL NUCLEAR MEDICINE, 1989, 14 (07) :515-522
[8]  
HARTMANN O, 1990, CANCER ENFANT
[9]   I-131 METAIODOBENZYLGUANIDINE - DIAGNOSTIC USE IN NEURO-BLASTOMA PATIENTS IN RELAPSE [J].
HEYMAN, S ;
EVANS, AE ;
DANGIO, GJ .
MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (05) :337-340
[10]   CONSOLIDATING THE ROLE OF STAR-I-MIBG-SCINTIGRAPHY IN CHILDHOOD NEUROBLASTOMA - 5 YEARS OF CLINICAL-EXPERIENCE [J].
JACOBS, A ;
DELREE, M ;
DESPRECHINS, B ;
OTTEN, J ;
FERSTER, A ;
JONCKHEER, MH ;
MERTENS, J ;
HAM, HR ;
PIEPSZ, A .
PEDIATRIC RADIOLOGY, 1990, 20 (03) :157-159